In a nationwide effort to encourage all Americans to take steps to prepare for possible emergencies, the Federal Emergency Management Agency’s (FEMA) Ready Campaign and The Advertising Council have joined today with The Weather Channel® (TWC) to launch a new series of public service advertisements (PSAs). The PSAs are an extension of the national Ready PSA Campaign and will be distributed in advance of National Preparedness Month (NPM) in September.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/45754/
CVS/pharmacy has kicked-off its ninth annual in-store fund raising campaign to support the fight against amyotrophic lateral sclerosis (ALS). Since 2002, CVS/pharmacy has partnered with the ALS Therapy Alliance (ATA) to help advance ALS research. To date, CVS/pharmacy has raised more than $19 million in its stores—a single $1 donation at a time—to support the funding of new clinical research with the aim of discovering a treatment or cure for this devastating disease. This year's campaign began on June 6 and runs through June 26.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/44466/
Car crashes are the no. 1 cause of teen deaths and the fast-approaching summer months prove to be the deadliest. In advance of National Youth Traffic Safety Month® in May, The Allstate Foundation and National Organizations for Youth Safety® (NOYS) are partnering with TV star and singer Victoria Justice to encourage young adults to Act Out Loud® for stronger teen driving laws. Justice asks teens to visit Facebook.com/ActOutLoud to create an Act Out Loud Yearbook from now until May 6.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55118-allstate-noys-victoria-justice-act-out-loud-yearbook-youth-traffic-safety
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced that it has acquired Ireland-based QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries. The QUMAS acquisition further extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions. Proven quality management solutions supported by robust content and business process management capabilities provided by QUMAS advance Accelrys’ ability to help customers better manage the scientific innovation lifecycle by reducing regulatory risks, lowering quality costs, improving compliance effectiveness and increasing operational efficiency in bringing new products to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62188-accelrys-acquires-compliance-and-quality-management-leader-qumas
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Huawei today opened the 2nd Global Services Forum in Zurich, Switzerland. Under the theme of Re-architecting Infrastructure and Operations for New Growth, the two-day event brings together more than 300 guests from leading global carriers, standards organizations, open source communities, analyst institutions, partners, and media outlets. The forum this year is aiming at sharing experiences, innovations, best practices, and thought leadership to advance new growth on the journey of re-architecting operating model and ICT infrastructure in the fast changing digital era.
Eric Xu, Huawei’s Rotating and Acting CEO, delivered an opening speech titled A Shift in Mindset towards Customer Experience-driven Operations. In his speech, Xu explained the change of customer experience and how this change has influenced the ways carriers transform their operations and infrastructure.
To view the multimedia release go to:
http://www.multivu.com/players/English/7621151-huawei-global-services-forum/
